HIGHOutside partySupplier
sole or limited source suppliers
“10-K Item 1A: 'If we are unable to obtain key materials and components from sole or limited source suppliers, we will not be able to deliver our products to customers.'”
MASI · Concentration risk · 10-K extracted
Masimo (MASI) concentration risks
Updated
The most significant concentration Masimo discloses is sole or limited source suppliers, classified HIGH by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Source: Masimo’s SEC Form 10-K filed — view the filing on SEC EDGAR ↗
At a glance
Disclosed-size breakdown · 2 disclosed concentrations
HIGH1
MEDIUM1
LOW0
Disclosed concentrations
Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).
MEDIUMBuilt-inProduct / Revenue mix
Masimo SET® and rainbow SET® platforms
“10-K Item 1A: 'We currently derive a significant portion of our revenue from our Masimo SET® platform, Masimo rainbow SET® platform and related products.'”
TrendMatrix Research · concentration synthesis
What these concentrations mean together
updated 2026-06-24The company's concentration profile combines a supply-chain dependency and a product-mix exposure. On the supply side, the most pronounced disclosed risk is reliance on sole or limited source suppliers for key materials and components — a high-share exposure with a dependency character. If these suppliers cannot deliver, the filing states directly that the company will not be able to deliver products to customers, making this the most operationally consequential item in the disclosed profile. Unlike customer or geographic concentrations that can sometimes be partially absorbed, a sole-source supply disruption could interrupt production more abruptly. Layered on the supply dependency is a product-line exposure: a significant portion of revenue is currently derived from the Masimo SET and rainbow SET platforms and related products — a medium-share exposure with a structural character. The product concentration is inherent to the company's focus on proprietary monitoring platforms and is unlikely to change rapidly; it means that competitive pressure or technology substitution directed specifically at those platforms would flow through a meaningful portion of the revenue base. The two exposures interact in the sense that the products generating significant revenues are also the ones dependent on specialized components from limited sources. On balance, the sole-source supply dependency is the sharper near-term risk given its operational immediacy, while the platform-revenue concentration is the longer-term strategic variable to monitor.
For the engine’s reasoning on MASI’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.
Industry peers · Medical Devices
Peer concentration profile
| Symbol | Name | HIGH | MEDIUM | LOW | Total |
|---|---|---|---|---|---|
| AORT | Artivion, Inc. | 4 | 4 | 0 | 8 |
| ATEC | Alphatec Holdings, Inc. | 1 | 1 | 0 | 2 |
| MASI● | Masimo Corporation | 1 | 1 | 0 | 2 |
| ABT | Abbott Laboratories | 1 | 0 | 0 | 1 |
| AXGN | AxoGen, Inc. | 0 | 0 | 0 | 0 |
| BIO | Bio-Rad Laboratories, Inc. | 0 | 0 | 0 | 0 |
Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.